Analysed COMPASS THERAPEUTICS INC (CMPX:NASDAQ) News Sources
Compass Therapeutics to Present Promising Phase 1 Clinical Data for CTX-8371 in Patients with Advanced Malignancies Treated in the Post-Checkpoint Inhibitor Setting at the 2026 ASCO Annual Meeting
21-05-2026
yahoo.com
Compass Therapeutics Announces Tovecimig Data Accepted for an Oral Presentation at the ESMO Congress 2026
17-07-2026
yahoo.com
CMPX Stock Crashes To Over 2-Year Lows — Why FDA Wants Another Cancer Therapy Trial Before Key Marketing Filing
22-09-2026
stocktwits.com
CMPX Plunge Wipes Out $104M After FDA Demands Fresh Trial For Cancer Drug — Wedbush Sees Another 19% Downside
22-09-2026
stocktwits.com
Compass Therapeutics’ FDA Setback Raises Concerns On Wall Street — H.C. Wainwright Calls Tovecimig Filing Strategy ‘Risky’
23-09-2026
stocktwits.com
Compass Therapeutics (CMPX) Stock Fair Value Falls After Tovecimig Regulatory Concerns
14-10-2026
yahoo.com
What is the current price of COMPASS THERAPEUTICS INC (CMPX:NASDAQ)?
The current price of COMPASS THERAPEUTICS INC (CMPX:NASDAQ) is $0.7472.
COMPASS THERAPEUTICS INC (CMPX:NASDAQ) absolute price change since previous trading day?
The absolute price change of COMPASS THERAPEUTICS INC (CMPX:NASDAQ) since the previous trading day is $-0.0138.
COMPASS THERAPEUTICS INC (CMPX:NASDAQ) percentage price change since previous trading day?
The percentage price change of COMPASS THERAPEUTICS INC (CMPX:NASDAQ) since the previous trading day is -1.8134%.
What is the most recent average sentiment score for COMPASS THERAPEUTICS INC (CMPX:NASDAQ)?
The most recent average sentiment score for COMPASS THERAPEUTICS INC (CMPX:NASDAQ) is 59 out of 100.
What is the most recent average sentiment for COMPASS THERAPEUTICS INC (CMPX:NASDAQ)?
The most recent sentiment for COMPASS THERAPEUTICS INC (CMPX:NASDAQ) is .
SEC-8K** Filing Available For COMPASS THERAPEUTICS INC (CMPX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.